The serine/threonine protein kinase Akt is activated by a wide range of stimuli, such as growth factors and cytokines (Manning and Cantley, 2007) , and has been implicated in many aspects of cellular regulation, including cell survival, growth, proliferation, migration, and metabolism. Likewise, numerous Akt substrates have been identified that mediate these effects (Figure 1 ). Because phosphorylation of specific Akt substrates determines the cellular response, a major question in Akt signaling is how substrate selectivity is achieved. In this issue, Schenck et al. (2008) provide evidence for the role of spatial regulation in Akt signaling. They show that the binding of Akt to the endosomal protein Appl1 contributes to Akt's substrate selectivity and promotes cell survival in zebrafish development.
Human APPL1 (adaptor protein containing PH domain, PTB domain, and leucine zipper) was originally identified as an Akt-interacting protein (Mitsuuchi et al., 1999) . Subsequent studies have established that APPL1 is a direct downstream effector of Rab5 (Miaczynska et al., 2004) , a GTPase involved in endocytosis. In new work using a zebrafish model, Schenck et al. now show that downregulation of Appl1 or Appl2 by antisense morpholinos markedly increases apoptosis in tissues that normally have high levels of expression of Appl1 and Appl2 . A role for Appl2 in cell survival during development is further supported by genetic mutation analyses.
Previous work has shown that activity of mammalian Akt is enhanced by binding to APPL1 in response to various signals. Similarly, Schenck et al. show that activation of Akt by growth factor stimulation is diminished by morpholino knockdown of Appl1 in zebrafish. Based on these and other findings the authors conclude that Appl1 is essential for the prosurvival function of Akt. They then examined the effect of depleting Appl1 on the phosphorylation of two Akt substrates, glycogen synthase kinase 3 (Gsk3) and tuberous sclerosis protein 2 (Tsc2). Surprisingly, inactivation of Appl1 only decreases the phosphorylation of Gsk3 but not Tsc2 (Figure 1 ), suggesting that Appl1 may affect the substrate selectivity of Akt in vivo.
The colocalization of APPL1 with Akt and GSK3, but not TSC2, further supports the notion that Appl1 regulates Akt substrate selectivity . Human APPL1 is localized in multiple cellular compartments, including endosomes (Miaczynska et al., 2004 To further investigate the functional importance of the endosomal localization of Appl1 for Akt activation in zebrafish, the authors tested whether mutant Appl1 proteins that localize to other cellular compartments could rescue the apoptosis induced by knockdown of endogenous Appl1. The authors found that only endosomal Appl1 supports Akt activation and promotes cell survival; neither nuclear nor soluble Appl1 proteins could rescue apoptosis induced by the knockdown of Appl1. These observations reveal an exciting model in which Appl1 regulates Akt substrate selectivity, possibly by recruiting Akt and its substrate Gsk3 to the same subcellular compartment (Figure 1) .
In addition to spatial regulation, previous studies have indicated a role for signal strength in Akt substrate selectivity. The mammalian target of rapamycin complex 2 (mTORC2) is responsible for phosphorylation of Akt at serine 473, which increases kinase activity several-fold (Sarbassov et al., 2005) . Genetic deletion of Sin1 (an essential subunit of mTORC2) in mice abolishes serine 473 phosphorylation but has little effect on phosphorylation of threonine 308 in Akt's activation loop. Interestingly, cells lacking Sin1 display a severe defect in the phosphorylation of Foxo1, whereas the effect on Gsk3 and Tsc2 phosphorylation is minor (Jacinto et al., 2006) . This suggests that full activation of Akt is required for the phosphorylation of some but not all Akt substrates.
Together, these studies demonstrate that Akt substrate specificity can be controlled by multiple mechanisms, including signal strength and spatial regulation.
The report by Schenck et al. provides new insights into the substrate selectivity of Akt but also raises many important questions regarding Akt signaling and APPL1. How does APPL1 enhance Akt phosphorylation? Does it recruit mTORC2 to the endosome? APPL1 is known to interact with numerous cellsurface receptors, including receptors for nerve growth factor, follicle-stimulating hormone, and adiponectin. Does APPL1 play a general role in dictating signaling specificity of these interacting proteins? If APPL1 mainly contributes to cell survival, it should promote phosphorylation of Akt substrates such as BAD and FOX1 that regulate apoptosis but not the phosphorylation of substrates that regulate proliferation, such as p27. Future work may also reveal mechanisms other than spatial regulation and signal strength that contribute to the signaling specificity of Akt.
